Kinfo
Bionexus Gene Lab Corp. logo

Bionexus Gene Lab Corp.

BGLCNASDAQBasic Materials·US · USD
$1.58
+0.02 (+1.28%)
Prices as of August 11, 2026 · live

Price

Key statistics

Valuation
Market cap3.77M USD
Enterprise value346.06K USD
Trailing P/E-0.98
Forward P/E0.00
PEG ratio0.03
Price / sales0.71
Price / book0.47
Profitability
Gross margin-3.46%
Operating margin-2466.01%
Profit margin-54.70%
Return on assets-20.76%
Return on equity-36.62%
Income (TTM)
Revenue5.31M USD
Gross profit740.93K USD
EBITDA-2.96M USD
Net income-2.90M USD
Diluted EPS-$1.49
Rev. growth (YoY)-98.90%
Balance sheet
Total cash3.96M USD
Total debt346.62K USD
Debt / equity4.28
Current ratio6.52
Book value / share$3.35
Cash flow (TTM)
Operating cash flow-1.16M USD
Levered free cash flow-170.05K USD
Shares & price
Shares outstanding2.42M
Float1.36M
Held by institutions0.01%
Beta2.19
50-day MA$1.92
200-day MA$2.88
52-week high$6.10
52-week low$1.07
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-02-121.031.07+3.88%
About Bionexus Gene Lab Corp.

Bionexus Gene Lab Corp. operates as a biotechnology company with a focus on the research and development of genomic sequencing and analysis solutions. Its primary function is to advance personalized medicine by utilizing its genetic technologies to assist healthcare professionals in identifying and customizing treatment plans for patients based on their unique genetic profiles. Notable features of Bionexus Gene Lab Corp. include its cutting-edge laboratory facilities and a comprehensive database of genetic information, which enable it to provide accurate and efficient genomic testing services. The company plays a significant role in the healthcare and biopharmaceutical sectors, impacting areas such as precision oncology, hereditary disease prevention, and drug development. By facilitating a deeper understanding of genetic predispositions and responses, Bionexus Gene Lab Corp. is integral to the evolution of targeted therapies and personalized healthcare treatments, reflecting its importance in advancing modern medical practices.

Sector
Basic Materials
Industry
Specialty Chemicals
CEO
Mr. Su-Leng Tan
Employees
19
Headquarters
Kuala Lumpur, Malaysia

Frequently asked questions about Bionexus Gene Lab Corp.